AD-221

DRUG2 trials

Sponsors

Addpharma Inc.

Conditions

HyperlipidemiasPrimary Hypercholesterolemia

Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B

CompletedNCT05202405

Addpharma Inc.Hyperlipidemias

Start: 2022-01-05End: 2022-03-04Updated: 2022-07-20

Phase 3

A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

CompletedNCT05131997

Addpharma Inc.Primary Hypercholesterolemia

Start: 2021-11-16End: 2022-06-08Updated: 2022-07-20

Related Papers

Comparison of pharmacokinetics of a fixed-dose combination of atorvastatin/ezetimibe 5 mg/10 mg versus separate tablets in healthy subjects

Translational and Clinical Pharmacology2025-01-01